Boltt

Sector: Pharma & Healthcare (Fitness Wearables & Continuous Glucose Monitoring (CGM) Plant)  |  HQ: India  |  Founded: Not separately disclosed  |  Employees: Not separately disclosed

Listed as: Privately held  | 

Company overview

Boltt operates in the pharma & healthcare segment of the Indian market, with a presence noted in the fitness wearables & continuous glucose monitoring (cgm) plant category. The company is among the recognised participants in this segment alongside other Indian and multinational players. Operations follow the standard Companies Act 2013 disclosure framework where Boltt is incorporated as a private or public limited company under Indian law, with statutory audit, GST registration under the CGST Act 2017, and applicable sectoral compliance under FSSAI, BIS, MoEF, or sectoral regulators as relevant to the activity. The competitive set in fitness wearables & continuous glucose monitoring (cgm) plant includes pan-India brands, regional players, and multinational subsidiaries operating in India through wholly-owned or joint-venture structures.

Recent developments

September 2025 - March 2026

Fire-Boltt's most significant recent development is the September 2025 launch of FireLens, India's first AI-powered smart eyewear [2,3]. The product line features vision AI capabilities including camera functionality and real-time translation, representing the company's expansion beyond smartwatches into the smart eyewear segment [6,7]. Forbes India profiled the young founder's ambition to position India centrally in the future of wearables [1], while GQ India covered the strategic foray into smart eyewear as a new innovation category [5].

Historically, Fire-Boltt has demonstrated strong market traction in India, having led Q2 2022 smartwatch shipments during the country's highest-ever quarterly volumes [10] and notably surpassing Samsung for the first time in global smartwatch shipments in May 2023 [9]. The company also announced plans to begin exporting from India starting February 2023 [8], indicating an early-stage international expansion strategy that preceded the 2025 smart eyewear diversification.

Sources (9)

1. FireLens and the young founder betting on India’s place in the future of wearables - Forbes India · Forbes India · Wed, 24 Sep 2025
2. Fire Boltt introduces FireLens, India's first AI-powered smart eyewear: Price, features - Moneycontrol.com · Moneycontrol.com · Fri, 19 Sep 2025
3. Fire-Boltt Ushers in a Vision Revolution with FireLens: India's First AI-Powered Smart Eyewear - Business Standard · Business Standard · Tue, 16 Sep 2025
4. Fire-Boltt forays into the smart eyewear with its latest innovation - GQ India · GQ India · Fri, 10 Oct 2025
5. Fire-Boltt launches FireLens Audio and AI Vision Smart Eyewear in India - MobiGyaan · MobiGyaan · Sat, 20 Sep 2025
6. Fire-Boltt FireLens Vision AI debuts in India with camera, translation and AI features - Gizmochina · Gizmochina · Sun, 21 Sep 2025
7. Fire-Boltt to start exports from India from Feb: CEO - ET Telecom · ET Telecom · Thu, 19 Jan 2023
8. India's Fire-Boltt surpasses Samsung for first time in global smartwatch shipments - The Economic Times · The Economic Times · Fri, 26 May 2023
9. India’s Q2 Smartwatch Shipments Highest Ever, Fire-Boltt Leads - Counterpoint Research · Counterpoint Research · Thu, 18 Aug 2022

Financial performance and recent trajectory

Disclosed revenue (FY25): Not separately disclosed in segment-wise FY 2024-25 reporting.

Competitive position

Boltt occupies a position in the fitness wearables & continuous glucose monitoring (cgm) plant category alongside other listed and unlisted Indian players. Competitive intensity in the segment is shaped by raw material cost cycles, distribution depth, branded versus unbranded share, and the regulatory framework governing manufacturing, FSSAI labelling (for food), BIS standards (for engineering goods), or sectoral norms. The principal competitive moats in this category are typically scale, distribution reach, brand trust, and integrated procurement. KAMRIT's project report on fitness wearables & continuous glucose monitoring (cgm) plant benchmarks new entrant economics against the listed peer cost structure including capex per tonne (or per unit of output), working capital intensity, gross margin band, and the EBITDA delta between organised and unorganised participants.

Key risks

Input cost volatility in the fitness wearables & continuous glucose monitoring (cgm) plant value chain Competitive intensity from larger Indian groups and multinational subsidiaries Regulatory tightening under FSSAI, BIS, environmental norms, or labour codes

Outlook

Boltt is a participant in the Indian fitness wearables & continuous glucose monitoring (cgm) plant category, which forms part of the broader Pharma & Healthcare space. The Indian fitness wearables & continuous glucose monitoring (cgm) plant market continues to evolve with rising organised share, premiumisation, distribution expansion, and a regulatory architecture covering the Companies Act 2013, the Income Tax Act 1961, the CGST Act 2017, the Legal Metrology Act 2009, and sectoral statutes including the Food Safety and Standards Act 2006 (for food and beverage subsegments), the Drugs and Cosmetics Act 1940 (for pharmaceutical or healthcare adjacencies), the Environment Protection Act 1986 (for emissions and effluents), and labour codes consolidated under the four 2020 labour codes. In KAMRIT's project report framework for this category, the competitive set typically includes pan-India branded leaders, multinational subsidiaries, mid-sized regional players, and a long tail of MSME participants. The structural attractiveness of the category for new entrants is a function of (a) market growth rate, (b) the share that remains with unorganised or fragmented operators, (c) the cost of regulatory compliance, and (d) the capex intensity of plant and machinery. The KAMRIT bankable DPR for this category structures a new entrant's economics against this competitive landscape. For Boltt specifically, public-domain disclosures provide a baseline view of operations, but segment-wise revenue, EBITDA, capacity utilisation, and forward capex plans are not separately broken out in many cases. Where the company is part of a listed group, the SEBI LODR and the Companies Act 2013 governance framework apply, with statutory audit conducted under SA 700 and CARO 2020 reporting. Where the company is unlisted, the Companies Act 2013 framework continues to govern with reduced public disclosure. The risk and opportunity outlook for Boltt mirrors the broader fitness wearables & continuous glucose monitoring (cgm) plant category dynamics. Demand-side drivers include rising household consumption, urbanisation, organised retail expansion, and policy support including PLI schemes (where applicable to the segment). Supply-side risks include input cost volatility, regulatory tightening, environmental compliance escalation, and competitive intensity from larger groups or imports. Management quality, balance sheet strength, distribution depth, and the capex execution track record are the differentiators within the peer set. KAMRIT's research desk maintains a baseline reference for Boltt as a peer benchmark within the fitness wearables & continuous glucose monitoring (cgm) plant category. For investors, lenders, or new entrant promoters seeking a fuller assessment of Boltt, KAMRIT's deep-dive company profile engagement covers financial trajectory, capacity and capex, distribution and customer concentration, regulatory exposure, and the competitive position with named peers.

KAMRIT point of view

Building or competing with Boltt?

KAMRIT advises promoters, family offices, and global enterprises evaluating greenfield entry into the pharma & healthcare (fitness wearables & continuous glucose monitoring (cgm) plant) sector. Our Bankable DPR with Cost Model and ROI benchmarks your project economics against the listed-company cost structure of Boltt and peers. The Execution Partnership tier covers everything from incorporation through commissioning. A 20-minute scoping call with our partners is free.

View all 1 related project report → Book a scoping call

Related KAMRIT project reports

These reports use Boltt in benchmarking and competitive analysis sections.

Disclaimer: This profile is compiled by KAMRIT Financial Services LLP for educational and benchmarking purposes only. It is not investment advice, a recommendation to buy or sell securities, or a solicitation. Stock data is provided by Yahoo Finance and may be delayed by up to 20 minutes. Company financial commentary draws on publicly available filings, exchange disclosures, and KAMRIT industry research. Readers should consult a SEBI-registered investment adviser before making investment decisions. KAMRIT is a financial services and compliance firm, not a SEBI-registered investment adviser.